Skip to content

Clinical trials

Phase 4 Purpura, Thrombocytopenic, Idiopathic trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Phase: Phase 4 Country / region: China Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20131
20152
20171
20192
20202
20222
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status5
Recruiting3
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shandong University6
Institute of Hematology & Blood Diseases Hospital, China4
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology2
Fujian Medical University Union Hospital1
Novartis Pharmaceuticals1
Qidong Gaitianli Medicines Co., Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic15
Thrombocytopenia2
Leukemia, Myeloid, Acute1
Myelodysplastic Syndromes1
Purpura1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.